These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 37747595)

  • 1. Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways.
    Li H; Liu J; Qin X; Sun J; Liu Y; Jin F
    Cell Mol Neurobiol; 2023 Nov; 43(8):3929-3942. PubMed ID: 37747595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
    Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
    Tomar VS; Patil V; Somasundaram K
    Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways.
    Yang J; Yang Q; Yu J; Li X; Yu S; Zhang X
    Oncol Rep; 2016 Jun; 35(6):3566-76. PubMed ID: 27108836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling cascade: A promising target for glioma therapy.
    He L; Zhou H; Zeng Z; Yao H; Jiang W; Qu H
    J Cell Physiol; 2019 Mar; 234(3):2217-2228. PubMed ID: 30277583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WDR34 affects PI3K/Akt and Wnt/β-catenin pathways to regulates malignant biological behaviors of glioma cells.
    Zuo J; Liu C; Ni H; Yu Z
    J Neurooncol; 2022 Jan; 156(2):281-293. PubMed ID: 34981299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response.
    Sharma U; Murmu M; Barwal TS; Tuli HS; Jain M; Prakash H; Kaceli T; Jain A; Bishayee A
    Curr Oncol; 2022 Mar; 29(4):2326-2349. PubMed ID: 35448163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway.
    Xiang Z; Lv Q; Chen X; Zhu X; Liu S; Li D; Peng X
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32735016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt /β-catenin signaling.
    Tang Q; Zheng X; Zhang J
    Biomed Pharmacother; 2018 Jul; 103():1187-1193. PubMed ID: 29864897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
    Barzegar Behrooz A; Talaie Z; Jusheghani F; Łos MJ; Klonisch T; Ghavami S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review.
    Shahcheraghi SH; Tchokonte-Nana V; Lotfi M; Lotfi M; Ghorbani A; Sadeghnia HR
    Curr Pharm Des; 2020; 26(15):1729-1741. PubMed ID: 32003685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
    Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
    Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer.
    Thapa R; Afzal O; Gupta G; Bhat AA; Almalki WH; Alzarea SI; Kazmi I; Altamimi ASA; Subramaniyan V; Thangavelu L; Singh SK; Dua K
    Pathol Res Pract; 2023 Sep; 249():154736. PubMed ID: 37579591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01198 facilitates gliomagenesis through activating PI3K/AKT pathway.
    Xie Y; Cheng Y
    RNA Biol; 2020 Jul; 17(7):1040-1052. PubMed ID: 32378450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel splice variants of LINC00963 suppress colorectal cancer cell proliferation via miR-10a/miR-143/miR-217/miR-512-mediated regulation of PI3K/AKT and Wnt/β-catenin signaling pathways.
    Ghaemi Z; Mowla SJ; Soltani BM
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194921. PubMed ID: 36804476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propofol and Sevoflurane Alleviate Malignant Biological Behavior and Cisplatin Resistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-catenin Pathway and PI3K/AKT Pathway.
    Quan Y; Li S; Wang Y; Liu G; Lv Z; Wang Z
    Anticancer Agents Med Chem; 2022; 22(11):2098-2108. PubMed ID: 35152870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.